Skip to main content

Table 2 Previous and concomitant preventive treatments at baseline

From: Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients

Medication

Previous [n (%)]

Concomitant [n (%)]

Topiramate

138 (85.2)

12 (7.4)

Beta-blocker

117 (72.2)

33 (20.4)

Amitriptyline

140 (86.4)

25 (15.4)

Flunarizine

100 (61.7)

1 (0.6)

Anti-hypertensive

69 (42.6)

36 (22.2)

Onabotulinum toxin A

141 (87.0)

31 (19.1)

Others

103 (63.6)

44 (27.2)